Buy-side Merger and Capital Raise for Life Sciences Company
NOW Diagnostics, Inc.
Representation of a rapid assay diagnostics company in its acquisition of another rapid assay diagnostics company. The complex transaction involved a stock-for-stock merger and capital raise of Series B Convertible Preferred Stock, and included counsel on corporate governance, employment agreements, and corporate tax structuring.
Related Practices
RELATED PEOPLE
Associate
Partner
Practice Group Leader, Corporate & Finance
Associate
Associate
Of Counsel
MORE EXPERIENCE
Representation of Lennar Corporation in the formation of Lennar Multifamily Venture (LMV), an equity fund/joint venture sponsored and managed by Lennar Multifamily Communities with global sovereign and institutional investors. The venture, with initial equity commitments of $1.1 billion, targets inv...
Representation of real estate fund client in the private placement securities offering of a flagship private equity fund comprised of two separate real estate funds, one focused on debt investments and the other focused on direct residential and commercial investments. The funds' structures include ...
Advised and assisted Craig Robins, The Dacra Group, and affiliated entities regarding the acquisition of, and the selling of an equity interest in, a 20-plus property real estate portfolio in the Miami Design District, in order to make way for the $1.4 billion proposed development of the area.